Ashurst Perkins Coie LLP has opened a third office in Texas after hiring attorneys Tamara L. McKinzie and Thomas M. Tomlinson as partners.
Samsung Electronics America Inc. is facing a proposed class action in California federal court alleging its Smart TVs unlawfully intercept and monetize users' ...
Copyright © 2026 The respective authors. Distributed by JD Supra, LLC. All rights reserved. The national conversation about so-called junk fees — charges hidden until the final stage of a consumer ...
On 14 October 2026, the government published a consultation on reforming the employment status framework, as well as additional protections for the genuinely ...
The U.S. Food and Drug Administration (FDA) issued new draft guidance on premarket submissions for robotically assisted surgical devices (RASDs). We see the guidance as a notable ...
The Michigan Supreme Court narrows Michigan Consumer Protection Act exemption for residential builders and revives a conduct-specific standard under the Michigan Consumer Protecti ...
On September 29, 2026, the final phase of the Section 232 pharmaceutical tariffs established by Presidential Proclamation 11020 (the Proclamation), became effective, subjecting ma ...
Effective January 1, 2027, California will require certain federal Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR") filers with a California nexus to submit a complete ...
Recent state enforcement actions and legislation involving artificial intelligence (AI) chatbots are testing how existing medical licensing, consumer protection and healthcare regulatory requirements ...
Washington expanded its material health care transaction notice law in 2026. Engrossed Substitute House Bill 2548, enacted as Chapter 222 of the 2026 Washington Laws, took effect ...
The Maryland federal court declined to block Executive Order 14398, instead interpreting its prohibition on "racially discriminatory DEI activities" as only barring intentional di ...
On October 14, 2026, the Food and Drug Administration (FDA) announced the launch of a Rare Disease Framework Initiative to advance a regulatory framework "purpose-built" for the d ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results